A research study titled, Synthetic
Biology Market by Product (Oligonucleotide
Synthesis, DNA Synthesis, Standardized DNA Parts, Synthetic Genes, Chassis
Organisms) and Application (Agriculture, Chemicals, Biofuels, Healthcare) -
Global Industry Analysis and Forecast to 2025” published by Crystal Market
Research, states that the synthetic biology market is projected to be around
$26 billion by 2025.
Synthetic biology
refers to interdisciplinary
area used for creating
new biological parts, devices, and systems with the help of engineering
principles. It can be used to developbio-products, advanced biofuels, renewable
materials, and bio-based specialty chemicals. Synthetic biology can be used to
identify and catalog standardized genomic parts which can be synthesized
quickly and used to build novel biological systems. In natural product
synthesis, synthetic biology can be used to produce necessary enzymes along
with biological functions to carry out complex multi-stage production of
natural products. In biofuels, synthetic biology can be used for optimization
of genes and microorganisms to efficiently convert feedstock into biofuels.
Synthetic biology is anticipated to witness adoption in varied industries such
as agriculture, energy, pharmaceuticals, and chemicals. In medicine, synthetic
biology can be used for manufacturing of drugs, diagnostic agents and vaccines
and in creation of new tissues. In chemical industry, synthetic biology can be
used in the production of fine or bulk chemicals such as proteins to provide a
substitute to existing synthetic fibers or natural fibers.
Browse full research report with TOC
on “Synthetic Biology Market by Product and Application - Global Industry
Analysis and Forecast to 2025” at: https://www.crystalmarketresearch.com/report/synthetic-biology-market
Reduction in the cost of DNA sequencing, rise in the development of genetically
engineered crops, increased research and development related expenditure of
biotechnology and pharmaceutical companies, growing demand for synthetic genes
are set to drive this market. On the other hand, stringent regulations related
to bio-safety & bio-security can restrict the growth of this market.
In 2016, enabled product segment occupied the major share of the
global synthetic biology market owing to growing demand for higher-value
specialty products. Besides, core product will grow at highest CAGR during the
forecast period owing to increasing use of synthetic genes and development of
DNA constructs. Healthcare segment occupied the major share of the overall
synthetic biology market in 2016 owing to high usage in developing economical
drugs and vaccines.
In 2016, Europe occupied the major share of the synthetic biology
market owing to rising government funding and increased R&D efforts. On the
other hand, Asia-Pacific is projected to witness significant growth in the
forecast period.
Strategic collaborations is the key strategy adopted by the
leading players in the market. For instance, in May 2017, Oxford Genetics (a
leading synthetic biology-based technology company) entered into a
non-exclusive licensing agreement with ERS Genomics. This agreement grants
Oxford Genetics to access ESR’s foundational intellectual property about
CRISPR/Cas9 gene editing technology. Similarly, in May 2016, Bayer and ESR
Genomics entered into a patent license agreement. As per the terms of
agreement, Bayer obtained access to ESR’s genome editing patent portfolio (i.e.
CRISPR-Cas9) for cross divisional applications in its strategic business areas.
Request a sample copy of Synthetic
Biology Market Research Report @ https://www.crystalmarketresearch.com/report-sample/HC06129
Some of the leading players in the global synthetic biology market
are New England Biolabs, Inc., Synthetic Genomics Inc., Integrated DNA
Technologies, Inc.,DuPont,Amyris, Inc., GenScript, Intrexon Corporation, Gingko
Bioworks, Thermo Fisher Scientific Inc., Intrexon Corporation,
and Agilent Technologies, Inc.
Key Findings of the Research Study:
·
Enabled
product segment accounted for the largest share of the overall market in 2016
·
Core
product category is poised to be the fastest-growing segment during the
forecast period
·
Europe
dominated the global market for synthetic biology in 2016 due to increased
R&D efforts for the development of synthetic biology products
·
Asia-Pacific
is expected to grow at double digit CAGR during the forecast period due to high
demand for synthetically manufactured crops and rising awareness about
synthetic biology
Inquire more about this report at: https://www.crystalmarketresearch.com/send-an-enquiry/HC06129
Synthetic Biology Market
Segmentation:
By
Product:
- Enabling Products
- Oligonucleotide Synthesis
- DNA Synthesis
- Core Products
- Standardized DNA Parts
- Synthetic Genes
- Chassis Organisms
- Enabled Products
By Application:
- Agriculture
- Chemicals
- Biofuels
- Healthcare
- Others
By
Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- United Arab Emirates
- Others
Get Customization in the Report At: https://www.crystalmarketresearch.com/customization/HC06129
About Crystal Market Research
Crystal Market Research is a U.S.
based market research and business intelligence company. Crystal offers one
stop solution for market research, business intelligence, and consulting
services to help clients make more informed decisions. It provides both
syndicated as well as customized research studies for its customers spread
across the globe. The company offers market intelligence reports across a broad
range of industries including healthcare, chemicals & materials,
technology, automotive, and energy.
Contact:
Judy
304 South Jones Blvd, Suite
1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Website: http://www.crystalmarketresearch.com
No comments:
Post a Comment